Tuesday, April 7, 2015 | 8:30 AM - 5:00 PM
Keynote Speaker: James W. Mier (Beth Israel Deaconess Medical Center/ Harvard Medical School, Boston, MA)
Speakers: Renier J. Brentjens (Memorial Sloan Kettering Cancer Center), Stephen D. Gillies (Provenance Biopharmaceuticals, Carlisle, MA), Jerome Ritz (Harvard Medical School), Gilles Uzé (Université Montpellier II, Montpellier, France), K. Dane Wittrup (Massachusetts Institute of Technology, Cambridge, MA)
Systemic toxicity currently prevents exploiting the potential of many cytokines to treat cancer, viral infections, inflammatory and autoimmune conditions. Targeted delivery of immune-stimulatory or immune-regulatory cytokines offers much promise.
Thursday, April 16, 2015 | 8:00 AM - 7:00 PM
Keynote Speaker: Frank Hu (Harvard School of Public Health)
Speakers: Brian Bennett (University of North Carolina), Kevin Hall (National Institutes of Health), Rudolph Leibel (Columbia University), Patricia Mabry (National Institutes of Health), Anne McCartney (University of Reading), Christina A. Roberto (Harvard T.H. Chan School of Public Health)
This one-day conference will highlight the connection between nutrition and the complex science of preventing disease. Speakers will focus on promotion of optimal metabolic health, building on input from several complementary disciplines.
Monday, April 27, 2015 | 8:30 AM - 4:15 PM
Speakers: Erwan Bezard (University of Bordeaux),
Patrick Brundin (Van Andel Institute), Anna Sauerbier (NPF Parkinson's International Centre of Excellence, Kings College London), Marie-Francoise Chesselet (David Geffen School of Medicine at UCLA), Maurizio Facheris (Michael J. Fox Foundation for Parkinson's Research), Horacio Kaufmann (NYU Langone Medical Center), Olivier Rascol (Toulouse University Hospital), Daniel Weintraub (University of Pennsylvania)
This symposium will review clinical tools for the diagnosis and treatment of non-motor symptoms of Parkinson's disease, discuss the disease mechanisms, and address preclinical models for the development of new therapeutics.
Thursday, May 21, 2015 | 9:00 AM - 5:00 PM
Speakers: Stephen J. Forman (City of Hope), Thomas F. Gajewski (The University of Chicago Medicine), Carl June (University of Pennsylvania), David Kaufman (Merck Research Laboratories), Mark R. Litzow (Mayo Clinic), Andy Minn (University of Pennsylvania), Elaine Pinheiro (Merck Research Laboratories), Robert Vonderheide (University of Pennsylvania)
Cancer immunotherapy leverages advances in genetic, cellular, and biochemical technologies, and offers significant promise. This symposium unites immunotherapy and immunology experts to discuss emerging approaches, challenges and opportunities.
June 15 - 17, 2015
Chemists, toxicologists, drug developers, pharmacists, clinicians, and public health researchers will convene to explore research aimed at improving therapeutic countermeasures and diagnostic technologies against chemical threat agents.
Tuesday, March 24, 2015 | 11:45 AM - 4:00 PM
Speakers: P. Jeffrey Conn (Vanderbilt University), Ron Dror (Stanford University), Christopher Fotsch (Amgen), Corey Hopkins (Vanderbilt University), Whitney Nolte (Pfizer)
In this symposium, academic and industry scientists will describe the identification, characterization, and development of PAMs for challenging GPCRs.
Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM
Speakers: Chad Cowan (Harvard University), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)
The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.
Tuesday, December 9, 2014 | 8:00 AM - 5:00 PM
Speakers: Matthew D. Breyer (Eli Lilly and Company), Frank C. Brosius (University of Michigan Medical School), Benjamin D. Humphreys (Brigham and Women's Hospital), Matthias Meier (F. Hoffmann-La Roche Ltd), Shahnaz Shahinfar (S. Shahinfar Consulting, Inc. and The Children's Hospital of Philadelphia), Katalin Susztak (University of Pennsylvania), Aliza Thompson (Food and Drug Administration)
Identifying and prosecuting drug targets is challenging due to a poor understanding of pathogenesis and few biomarkers. This symposium identifies targets for preventive or therapeutic interventions and discusses challenges in clinical development.
November 11 - 13, 2014
Keynote Speaker:Thomas R. Insel (National Institute of Mental Health)
Speakers: Tracy L. Bale (University of Pennsylvania), Jay Belsky (University of California, Davis), Maureen Black (University of Maryland), Pia Britto (UNICEF), Serena Counsell (King's College London), Martha Farah (University of Pennsylvania), Edward Frongillo (University of South Carolina), Michael Georgieff (University of Minnesota), Takao Hensch (Harvard University), Sharon Lynn Kagan (Columbia University), Patricia Kuhl (Washington University), Ed Lein (Allen Institute for Brain Science), Betsy Lozoff (University of Michigan), Linda Mayes (Yale School of Medicine), Andrew N. Meltzoff (Washington University), Charles A. Nelson (Harvard University and Boston Children's Hospital), Joseph Piven (UNC School of Medicine, CIDD), Dana Suskind (University of Chicago), Nim Tottenham (UCLA)
Discover the latest cognitive neuroscience research on infant and early childhood development; social, family, and nutritional factors that cause lasting changes to the brain; and intervention, education, and policy to help at-risk children.
Edited by Daniel H. Geschwind
(University of California, Los Angeles)
Scholarly reviews of topics in neurology and psychiatry--a new Annals series.
Edited by Emmanuel Bigand
(University of Bourgogne), Barbara Tillmann
(Lyon Neuroscience Research Center), Isabelle Peretz
(University of Montreal), Robert J. Zatorre
(McGill University), Luisa Lopez
(University of Rome), and Maria Majno
(Pierfranco and Luisa Mariani Foundation)
This Annals volume highlights neuroscience research on the unique contributions of music to programs of cognitive stimulation and rehabilitation, including music-based interventions for neurological disorders such as Parkinson’s disease, dementia, and Alzheimer’s disease.
Organizers: Magdalena Alonso-Galicia (MAG Pharma Consulting LLC), Ken Jones (Allergan), Scott MacDonnell (Boehringer Ingelheim Pharmaceuticals), and Jennifer Henry (formerly at The New York Academy of Sciences)
This eBriefing reviews targets for preventive or therapeutic interventions in diabetic kidney disease and discusses clinical development.
Keynote Speaker: Thomas R. Insel (National Institute of Mental Health, NIH)
This eBriefing explores cognitive neuroscience research on early development, environmental factors that cause lasting changes in the brain, and initiatives to help at-risk children.
Foods high in antioxidants are believed to fight oxidative stress. But what is oxidative stress? Two scientists from a recent NYAS conference break it down and discuss whether antioxidants have superpowers.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
Neuropsychologist Jeffrey Halperin is using behavioral therapy on preschoolers with attention deficit hyperactivity disorder (ADHD). He hopes to train their brains to develop in new ways and if effective, his therapies could offer permanent, drug-free treatment for the disorder.
Researchers at Harvard have discovered why the headaches of some migraine sufferers worsen when the person is exposed to light. Rami Burstein, the study's senior author, explains what's happening in the brain, and how they made the breakthrough.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.